정형외과용 생체재료 시장 분석 및 예측(-2035년) : 유형별, 제품 유형별, 용도별, 기술별, 최종 사용자별, 재료 유형별, 기기별

Orthobiologics Market is anticipated to expand from $6.8 billion in 2024 to $10.5 billion by 2034, growing at a CAGR of approximately 4.5%. The Orthobiologics Market encompasses biologically derived products used to enhance the healing of musculoskeletal injuries. These products, including bone grafts, stem cells, and platelet-rich plasma, leverage natural substances to expedite recovery and improve outcomes. The market is driven by increasing sports injuries, an aging population, and advancements in regenerative medicine. Innovations focus on minimally invasive procedures and personalized treatment, with significant growth anticipated in emerging markets due to rising healthcare investments and awareness.

The Orthobiologics Market is experiencing robust growth, driven by the increasing adoption of biologic therapies in orthopedic treatments. Among segments, bone graft substitutes are top performers, with synthetic grafts and demineralized bone matrix leading due to their versatility and reduced risk of infection. The viscosupplementation segment is the second highest performer, propelled by the rising prevalence of osteoarthritis and demand for minimally invasive procedures. Within the cell-based segment, stem cell therapy shows promising potential, as it offers regenerative solutions for cartilage repair. Platelet-rich plasma (PRP) is also gaining attention, especially in sports medicine, for its role in accelerating healing processes. The demand for allografts continues to grow, driven by advancements in tissue engineering and increased availability. Innovations in delivery systems and personalized medicine are expected to further enhance the market's expansion. The emphasis on research and development underscores the market's commitment to improving patient outcomes.

Market Snapshot:

The Orthobiologics Market is experiencing dynamic shifts in market share, pricing strategies, and new product launches. The growing demand for minimally invasive procedures and regenerative medicine is propelling the market forward. Key players are focusing on innovative product development to enhance their portfolios. Pricing strategies are becoming more competitive, driven by the need to capture larger market segments and cater to diverse consumer needs. The introduction of advanced orthobiologic products is reshaping traditional treatment paradigms, offering significant potential for market growth. In the competitive landscape, companies are leveraging strategic alliances and mergers to gain a competitive edge. Regulatory influences, particularly in North America and Europe, are pivotal in shaping market dynamics. Stringent approval processes and compliance requirements present both challenges and opportunities. Emerging markets in Asia-Pacific are witnessing increased investments, driven by favorable regulatory changes and growing healthcare infrastructure. The market's future trajectory is promising, with advancements in biologic materials and personalized medicine expected to drive further expansion.

Geographical Overview:

The orthobiologics market demonstrates diverse growth across various regions, each with unique opportunities and challenges. North America leads the market, driven by the aging population and increased demand for advanced orthopedic treatments. The region's strong healthcare infrastructure and investment in research further bolster its market position. Europe follows, with robust healthcare systems and a focus on innovative treatment options enhancing the market landscape. The Asia Pacific region is experiencing rapid expansion, propelled by rising healthcare expenditures and increasing awareness of orthobiologics benefits. Countries like China and India are emerging as vital growth pockets due to their large populations and improving healthcare access. In Latin America, Brazil and Mexico are witnessing notable advancements in orthobiologics adoption, supported by growing medical tourism and expanding healthcare facilities. The Middle East & Africa, though in nascent stages, show potential as governments invest in healthcare infrastructure and promote advanced medical treatments. These emerging markets present lucrative opportunities for stakeholders seeking to capitalize on untapped potential.

Key Trends and Drivers:

The Orthobiologics Market is experiencing robust growth, driven by an aging population and rising incidences of musculoskeletal disorders. Key trends include advancements in regenerative medicine, which are enhancing the effectiveness of orthobiologic products. The integration of cutting-edge technologies, such as 3D printing and biofabrication, is revolutionizing product development and customization. Increased investment in research and development by major industry players is accelerating innovation and expanding product portfolios. Additionally, the growing preference for minimally invasive procedures is bolstering demand for orthobiologics, as these products often reduce recovery time and improve patient outcomes. The regulatory landscape is evolving, with streamlined approval processes facilitating faster market entry for new products. Opportunities abound in emerging markets, where healthcare infrastructure improvements are increasing access to advanced treatments. Companies that focus on strategic partnerships and collaborations are well-positioned to capitalize on these trends. Furthermore, the emphasis on personalized medicine is driving the development of tailored orthobiologic solutions, presenting lucrative prospects for growth.

Restraints and Challenges:

The Orthobiologics Market is currently navigating through several significant restraints and challenges. Firstly, the high cost of orthobiologic products is a considerable barrier. These advanced medical solutions often come with substantial price tags, limiting their accessibility to a broader patient base. Many healthcare systems, especially in developing regions, struggle to afford these innovative treatments, impacting market penetration. Additionally, stringent regulatory frameworks pose challenges. The approval process for orthobiologics is rigorous and time-consuming, often delaying the introduction of new products to the market. This can stifle innovation and discourage investment in research and development. The market also faces challenges from limited clinical evidence. Although orthobiologics hold great promise, the lack of extensive, long-term clinical data can lead to skepticism among healthcare providers, affecting the adoption rate. Furthermore, reimbursement issues are prevalent. Many insurance companies are hesitant to cover orthobiologic treatments, considering them experimental or non-essential, which can deter patient uptake. Lastly, there is a knowledge gap among healthcare professionals. The complexity of orthobiologic products requires specialized training, which is not always readily available, hindering their effective utilization.

Key Players:

Orthofix Medical, RTI Surgical, SeaSpine Holdings, Anika Therapeutics, ISTO Biologics, Bioventus, Kuros Biosciences, Xtant Medical, Collagen Solutions, AlloSource, Osiris Therapeutics, Regentis Biomaterials, Cerapedics, Harvest Technologies, Amedica Corporation

Research Scope:

• Estimates and forecasts the overall market size across type, application, and region.
• Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
• Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
• Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
• Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
• Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
• Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

• 1.1 Market Size and Forecast
• 1.2 Market Overview
• 1.3 Market Snapshot
• 1.4 Regional Snapshot
• 1.5 Strategic Recommendations
• 1.6 Analyst Notes

2 Market Highlights

• 2.1 Key Market Highlights by Type
• 2.2 Key Market Highlights by Product
• 2.3 Key Market Highlights by Application
• 2.4 Key Market Highlights by Technology
• 2.5 Key Market Highlights by End User
• 2.6 Key Market Highlights by Material Type
• 2.7 Key Market Highlights by Device

3 Market Dynamics

• 3.1 Macroeconomic Analysis
• 3.2 Market Trends
• 3.3 Market Drivers
• 3.4 Market Opportunities
• 3.5 Market Restraints
• 3.6 CAGR Growth Analysis
• 3.7 Impact Analysis
• 3.8 Emerging Markets
• 3.9 Technology Roadmap
• 3.10 Strategic Frameworks
  • 3.10.1 PORTER's 5 Forces Model
  • 3.10.2 ANSOFF Matrix
  • 3.10.3 4P's Model
  • 3.10.4 PESTEL Analysis

4 Segment Analysis

• 4.1 Market Size & Forecast by Type (2020-2035)
  • 4.1.1 Demineralized Bone Matrix
  • 4.1.2 Synthetic Bone Substitutes
  • 4.1.3 Bone Morphogenetic Proteins
  • 4.1.4 Viscosupplementation Products
  • 4.1.5 Stem Cell Therapy
  • 4.1.6 Plasma-Rich Protein
  • 4.1.7 Bone Graft Substitutes
  • 4.1.8 Soft Tissue Repair
  • 4.1.9 Orthobiologic Devices
• 4.2 Market Size & Forecast by Product (2020-2035)
  • 4.2.1 Allografts
  • 4.2.2 Xenografts
  • 4.2.3 Autografts
  • 4.2.4 Biocomposites
  • 4.2.5 Ceramic-Based
  • 4.2.6 Polymer-Based
  • 4.2.7 Growth Factors
  • 4.2.8 Cell-Based Matrices
  • 4.2.9 Scaffolds
• 4.3 Market Size & Forecast by Application (2020-2035)
  • 4.3.1 Spinal Fusion
  • 4.3.2 Trauma Repair
  • 4.3.3 Reconstructive Surgery
  • 4.3.4 Osteoarthritis
  • 4.3.5 Fracture Recovery
  • 4.3.6 Sports Medicine
  • 4.3.7 Wound Care
  • 4.3.8 Maxillofacial Surgery
  • 4.3.9 Dental Applications
• 4.4 Market Size & Forecast by Technology (2020-2035)
  • 4.4.1 Nanotechnology
  • 4.4.2 Bioprinting
  • 4.4.3 Tissue Engineering
  • 4.4.4 Gene Therapy
  • 4.4.5 Biomaterials
  • 4.4.6 Regenerative Medicine
  • 4.4.7 Cryopreservation
  • 4.4.8 Bioreactors
  • 4.4.9 Microfluidics
• 4.5 Market Size & Forecast by End User (2020-2035)
  • 4.5.1 Hospitals
  • 4.5.2 Clinics
  • 4.5.3 Ambulatory Surgical Centers
  • 4.5.4 Research Institutes
  • 4.5.5 Orthopedic Centers
  • 4.5.6 Sports Organizations
  • 4.5.7 Academic Institutions
  • 4.5.8 Biotechnology Companies
  • 4.5.9 Pharmaceutical Companies
• 4.6 Market Size & Forecast by Material Type (2020-2035)
  • 4.6.1 Calcium Phosphate
  • 4.6.2 Calcium Sulfate
  • 4.6.3 Collagen
  • 4.6.4 Hydroxyapatite
  • 4.6.5 Polyethylene Glycol
  • 4.6.6 Chitosan
  • 4.6.7 Alginate
  • 4.6.8 Polylactic Acid
  • 4.6.9 Silk
• 4.7 Market Size & Forecast by Device (2020-2035)
  • 4.7.1 Bone Graft Harvesting Devices
  • 4.7.2 Orthobiologic Delivery Systems
  • 4.7.3 Biodegradable Implants
  • 4.7.4 Syringes
  • 4.7.5 Needles
  • 4.7.6 Scaffold Devices
  • 4.7.7 Cell Culture Devices
  • 4.7.8 Bioreactor Systems
  • 4.7.9 Cryogenic Storage Systems

5 Regional Analysis

• 5.1 Global Market Overview
• 5.2 North America Market Size (2020-2035)
  • 5.2.1 United States
    • 5.2.1.1 Type
    • 5.2.1.2 Product
    • 5.2.1.3 Application
    • 5.2.1.4 Technology
    • 5.2.1.5 End User
    • 5.2.1.6 Material Type
    • 5.2.1.7 Device
  • 5.2.2 Canada
    • 5.2.2.1 Type
    • 5.2.2.2 Product
    • 5.2.2.3 Application
    • 5.2.2.4 Technology
    • 5.2.2.5 End User
    • 5.2.2.6 Material Type
    • 5.2.2.7 Device
  • 5.2.3 Mexico
    • 5.2.3.1 Type
    • 5.2.3.2 Product
    • 5.2.3.3 Application
    • 5.2.3.4 Technology
    • 5.2.3.5 End User
    • 5.2.3.6 Material Type
    • 5.2.3.7 Device
• 5.3 Latin America Market Size (2020-2035)
  • 5.3.1 Brazil
    • 5.3.1.1 Type
    • 5.3.1.2 Product
    • 5.3.1.3 Application
    • 5.3.1.4 Technology
    • 5.3.1.5 End User
    • 5.3.1.6 Material Type
    • 5.3.1.7 Device
  • 5.3.2 Argentina
    • 5.3.2.1 Type
    • 5.3.2.2 Product
    • 5.3.2.3 Application
    • 5.3.2.4 Technology
    • 5.3.2.5 End User
    • 5.3.2.6 Material Type
    • 5.3.2.7 Device
  • 5.3.3 Rest of Latin America
    • 5.3.3.1 Type
    • 5.3.3.2 Product
    • 5.3.3.3 Application
    • 5.3.3.4 Technology
    • 5.3.3.5 End User
    • 5.3.3.6 Material Type
    • 5.3.3.7 Device
• 5.4 Asia-Pacific Market Size (2020-2035)
  • 5.4.1 China
    • 5.4.1.1 Type
    • 5.4.1.2 Product
    • 5.4.1.3 Application
    • 5.4.1.4 Technology
    • 5.4.1.5 End User
    • 5.4.1.6 Material Type
    • 5.4.1.7 Device
  • 5.4.2 India
    • 5.4.2.1 Type
    • 5.4.2.2 Product
    • 5.4.2.3 Application
    • 5.4.2.4 Technology
    • 5.4.2.5 End User
    • 5.4.2.6 Material Type
    • 5.4.2.7 Device
  • 5.4.3 South Korea
    • 5.4.3.1 Type
    • 5.4.3.2 Product
    • 5.4.3.3 Application
    • 5.4.3.4 Technology
    • 5.4.3.5 End User
    • 5.4.3.6 Material Type
    • 5.4.3.7 Device
  • 5.4.4 Japan
    • 5.4.4.1 Type
    • 5.4.4.2 Product
    • 5.4.4.3 Application
    • 5.4.4.4 Technology
    • 5.4.4.5 End User
    • 5.4.4.6 Material Type
    • 5.4.4.7 Device
  • 5.4.5 Australia
    • 5.4.5.1 Type
    • 5.4.5.2 Product
    • 5.4.5.3 Application
    • 5.4.5.4 Technology
    • 5.4.5.5 End User
    • 5.4.5.6 Material Type
    • 5.4.5.7 Device
  • 5.4.6 Taiwan
    • 5.4.6.1 Type
    • 5.4.6.2 Product
    • 5.4.6.3 Application
    • 5.4.6.4 Technology
    • 5.4.6.5 End User
    • 5.4.6.6 Material Type
    • 5.4.6.7 Device
  • 5.4.7 Rest of APAC
    • 5.4.7.1 Type
    • 5.4.7.2 Product
    • 5.4.7.3 Application
    • 5.4.7.4 Technology
    • 5.4.7.5 End User
    • 5.4.7.6 Material Type
    • 5.4.7.7 Device
• 5.5 Europe Market Size (2020-2035)
  • 5.5.1 Germany
    • 5.5.1.1 Type
    • 5.5.1.2 Product
    • 5.5.1.3 Application
    • 5.5.1.4 Technology
    • 5.5.1.5 End User
    • 5.5.1.6 Material Type
    • 5.5.1.7 Device
  • 5.5.2 France
    • 5.5.2.1 Type
    • 5.5.2.2 Product
    • 5.5.2.3 Application
    • 5.5.2.4 Technology
    • 5.5.2.5 End User
    • 5.5.2.6 Material Type
    • 5.5.2.7 Device
  • 5.5.3 United Kingdom
    • 5.5.3.1 Type
    • 5.5.3.2 Product
    • 5.5.3.3 Application
    • 5.5.3.4 Technology
    • 5.5.3.5 End User
    • 5.5.3.6 Material Type
    • 5.5.3.7 Device
  • 5.5.4 Spain
    • 5.5.4.1 Type
    • 5.5.4.2 Product
    • 5.5.4.3 Application
    • 5.5.4.4 Technology
    • 5.5.4.5 End User
    • 5.5.4.6 Material Type
    • 5.5.4.7 Device
  • 5.5.5 Italy
    • 5.5.5.1 Type
    • 5.5.5.2 Product
    • 5.5.5.3 Application
    • 5.5.5.4 Technology
    • 5.5.5.5 End User
    • 5.5.5.6 Material Type
    • 5.5.5.7 Device
  • 5.5.6 Rest of Europe
    • 5.5.6.1 Type
    • 5.5.6.2 Product
    • 5.5.6.3 Application
    • 5.5.6.4 Technology
    • 5.5.6.5 End User
    • 5.5.6.6 Material Type
    • 5.5.6.7 Device
• 5.6 Middle East & Africa Market Size (2020-2035)
  • 5.6.1 Saudi Arabia
    • 5.6.1.1 Type
    • 5.6.1.2 Product
    • 5.6.1.3 Application
    • 5.6.1.4 Technology
    • 5.6.1.5 End User
    • 5.6.1.6 Material Type
    • 5.6.1.7 Device
  • 5.6.2 United Arab Emirates
    • 5.6.2.1 Type
    • 5.6.2.2 Product
    • 5.6.2.3 Application
    • 5.6.2.4 Technology
    • 5.6.2.5 End User
    • 5.6.2.6 Material Type
    • 5.6.2.7 Device
  • 5.6.3 South Africa
    • 5.6.3.1 Type
    • 5.6.3.2 Product
    • 5.6.3.3 Application
    • 5.6.3.4 Technology
    • 5.6.3.5 End User
    • 5.6.3.6 Material Type
    • 5.6.3.7 Device
  • 5.6.4 Sub-Saharan Africa
    • 5.6.4.1 Type
    • 5.6.4.2 Product
    • 5.6.4.3 Application
    • 5.6.4.4 Technology
    • 5.6.4.5 End User
    • 5.6.4.6 Material Type
    • 5.6.4.7 Device
  • 5.6.5 Rest of MEA
    • 5.6.5.1 Type
    • 5.6.5.2 Product
    • 5.6.5.3 Application
    • 5.6.5.4 Technology
    • 5.6.5.5 End User
    • 5.6.5.6 Material Type
    • 5.6.5.7 Device

6 Market Strategy

• 6.1 Demand-Supply Gap Analysis
• 6.2 Trade & Logistics Constraints
• 6.3 Price-Cost-Margin Trends
• 6.4 Market Penetration
• 6.5 Consumer Analysis
• 6.6 Regulatory Snapshot

7 Competitive Intelligence

• 7.1 Market Positioning
• 7.2 Market Share
• 7.3 Competition Benchmarking
• 7.4 Top Company Strategies

8 Company Profiles

• 8.1 Orthofix Medical
  • 8.1.1 Overview
  • 8.1.2 Product Summary
  • 8.1.3 Financial Performance
  • 8.1.4 SWOT Analysis
• 8.2 RTI Surgical
  • 8.2.1 Overview
  • 8.2.2 Product Summary
  • 8.2.3 Financial Performance
  • 8.2.4 SWOT Analysis
• 8.3 SeaSpine Holdings
  • 8.3.1 Overview
  • 8.3.2 Product Summary
  • 8.3.3 Financial Performance
  • 8.3.4 SWOT Analysis
• 8.4 Anika Therapeutics
  • 8.4.1 Overview
  • 8.4.2 Product Summary
  • 8.4.3 Financial Performance
  • 8.4.4 SWOT Analysis
• 8.5 ISTO Biologics
  • 8.5.1 Overview
  • 8.5.2 Product Summary
  • 8.5.3 Financial Performance
  • 8.5.4 SWOT Analysis
• 8.6 Bioventus
  • 8.6.1 Overview
  • 8.6.2 Product Summary
  • 8.6.3 Financial Performance
  • 8.6.4 SWOT Analysis
• 8.7 Kuros Biosciences
  • 8.7.1 Overview
  • 8.7.2 Product Summary
  • 8.7.3 Financial Performance
  • 8.7.4 SWOT Analysis
• 8.8 Xtant Medical
  • 8.8.1 Overview
  • 8.8.2 Product Summary
  • 8.8.3 Financial Performance
  • 8.8.4 SWOT Analysis
• 8.9 Collagen Solutions
  • 8.9.1 Overview
  • 8.9.2 Product Summary
  • 8.9.3 Financial Performance
  • 8.9.4 SWOT Analysis
• 8.10 AlloSource
  • 8.10.1 Overview
  • 8.10.2 Product Summary
  • 8.10.3 Financial Performance
  • 8.10.4 SWOT Analysis
• 8.11 Osiris Therapeutics
  • 8.11.1 Overview
  • 8.11.2 Product Summary
  • 8.11.3 Financial Performance
  • 8.11.4 SWOT Analysis
• 8.12 Regentis Biomaterials
  • 8.12.1 Overview
  • 8.12.2 Product Summary
  • 8.12.3 Financial Performance
  • 8.12.4 SWOT Analysis
• 8.13 Cerapedics
  • 8.13.1 Overview
  • 8.13.2 Product Summary
  • 8.13.3 Financial Performance
  • 8.13.4 SWOT Analysis
• 8.14 Harvest Technologies
  • 8.14.1 Overview
  • 8.14.2 Product Summary
  • 8.14.3 Financial Performance
  • 8.14.4 SWOT Analysis
• 8.15 Amedica Corporation
  • 8.15.1 Overview
  • 8.15.2 Product Summary
  • 8.15.3 Financial Performance
  • 8.15.4 SWOT Analysis

9 About Us

• 9.1 About Us
• 9.2 Research Methodology
• 9.3 Research Workflow
• 9.4 Consulting Services
• 9.5 Our Clients
• 9.6 Client Testimonials
• 9.7 Contact Us